What does Daito Pharmaceutical do with its cash?

Cash conversion (operating CF ÷ operating income)

257.8%

Cash vs. profit gap

¥6.22B（純利益の 196.6%）

Shareholder returns

of net income 87.0% · of FCF 65.6%

Shareholder payments — dividends

of net income 35.4% · of FCF 26.7%

CapEx intensity (capex ÷ revenue)

10.2%

Investing CF relative to operating CF

46.8%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

• Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
• Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
• Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.